Effect of teriparatide on the healing of mandibular condylar osteochondral defects: A preclinical study

Published:February 23, 2022DOI:


      This study was performed to evaluate the effect of teriparatide therapy on the healing of osteochondral defects of the mandibular condylar. Ninety-six rats underwent surgery to create a defect in the condylar head on one side of the mandible, and were divided into two groups. One group received subcutaneous injection of 2 µg/kg/day teriparatide, and the other group received normal saline until sacrifice. On postoperative days 20, 40, and 60, 16 animals from each group were sacrificed, and bone and cartilage healing was histologically evaluated and semiquantitatively scored (1-5). The mean difference in healing score of the cartilaginous and subchondral parts of the defect between the teriparatide and control groups at days 20, 40 and 60 were 0.438 and 0.438, 0.813 and 0.750, and 1.125 and 0.813, respectively. The healing scores of the osteochondral defects in the teriparatide group were significantly (p< 0.05) higher than that in the control group at days 40 and 60. This study has shown beneficial effects of teriparatide on the healing of condylar osteochondral defects in rats. Clinical trials are required to extrapolate these findings to humans.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to British Journal of Oral and Maxillofacial Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Zhou H.Y.
        • Li Q.
        • Wang J.X.
        • et al.
        Low-intensity pulsed ultrasound repair in mandibular condylar cartilage injury rabbit model.
        Arch Oral Biol. 2019; 104: 60-66
        • Cheng M.S.
        • Yi X.
        • Zhou Q.
        Overexpression of HIF-1 alpha in bone marrow mesenchymal stem cells promote the repair of mandibular condylar osteochondral defect in a rabbit model.
        J Oral Maxillofac Surg. 2021; 79: e1-e15
        • Shapiro F.
        • Koide S.
        • Glimcher M.J.
        Cell origin and differentiation in the repair of full-thickness defects of articular cartilage.
        J Bone Joint Surg Am. 1993; 75: 532-553
        • Takafuji H.
        • Suzuki T.
        • Okubo Y.
        • et al.
        Regeneration of articular cartilage defects in the temporomandibular joint of rabbits by fibroblast growth factor-2: a pilot study.
        Int J Oral Maxillofac Surg. 2007; 36: 934-937
        • Kütük N.
        • Baş B.
        • Soylu E.
        • et al.
        Effect of platelet-rich plasma on fibrocartilage, cartilage, and bone repair in temporomandibular joint.
        J Oral Maxillofac Surg. 2014; 72: 277-284
        • Kalpakci K.N.
        • Kim E.J.
        • Athanasiou K.A.
        Assessment of growth factor treatment on fibrochondrocyte and chondrocyte co-cultures for TMJ fibrocartilage engineering.
        Acta Biomater. 2011; 7: 1710-1718
        • Blunk T.
        • Sieminski A.L.
        • Gooch K.J.
        • et al.
        Differential effects of growth factors on tissue-engineered cartilage.
        Tissue Eng. 2002; 8: 73-84
        • Zhang W.
        • Chen J.
        • Zhang S.
        • et al.
        Inhibitory function of parathyroid hormone-related protein on chondrocyte hypertrophy: the implication for articular cartilage repair.
        Arthritis Res Ther. 2012; 14: 221
        • Sampson E.R.
        • Hilton M.J.
        • Tian Y.
        • et al.
        Teriparatide as a chondroregenerative therapy for injury-induced osteoarthritis.
        Sci Transl Med. 2011; 3:101ra93
        • Orth P.
        • Cucchiarini M.
        • Zurakowski D.
        • et al.
        Parathyroid hormone [1-34] improves articular cartilage surface architecture and integration and subchondral bone reconstitution in osteochondral defects in vivo.
        Osteoarthritis Cartilage. 2013; 21: 614-624
        • Zandi M.
        • Dehghan A.
        • Zandipoor N.
        • et al.
        Effect of different doses and durations of teriparatide therapy on resolution of medication-related osteonecrosis of the jaw: a randomized, controlled preclinical study in rats.
        J Craniomaxillofac Surg. 2018; 46: 466-472
        • Kakehashi H.
        • Ando T.
        • Minamizato T.
        • et al.
        Administrationof teriparatide improves the symptoms of advanced bisphosphonates-related osteonecrosis of the jaw: preliminary findings.
        Int J Oral Maxillofac Surg. 2015; 44: 1558-1564
        • Zandi M.
        • Dehghan A.
        • Amini P.
        • et al.
        Evaluation of mandibular fracture healing in rats under zoledronate therapy: a histologic study.
        Injury. 2017; 48: 2683-2687
        • Kaito T.
        • Morimoto T.
        • Kanayama S.
        • et al.
        Modeling and remodeling effects of intermittent administration of teriparatide (parathyroidhormone 1–34) on bone morphogenetic protein-induced bone in a rat spinal fusion model.
        Bone Rep. 2016; 5: 173-180
        • Neuprez A.
        • Rompen E.
        • Crielaard J.M.
        • et al.
        Teriparatide therapy for denosumab induced osteonecrosis of the jaw in a male osteoporotic patient.
        Calcif Tissue Int. 2014; 95: 94-96
        • Kim K.M.
        • Park W.
        • Oh S.Y.
        • et al.
        Distinctive role of 6-month teriparatide treatment on intractable bisphosphonate-related osteonecrosis of the jaw.
        Osteoporos Int. 2014; 25: 1625-1632
        • Zandi M.
        • Dehghan A.
        • Mohammadi-Mofrad A.
        • et al.
        Short-term perioperative teriparatide therapy for the prevention of medication-related osteonecrosis of the jaw: a randomized, controlled preclinical study in rats.
        J Craniomaxillofac Surg. 2017; 45: 275-280
        • Liu Q.
        • Wan Q.
        • Yang R.
        • et al.
        Effects of intermittent versus continuous parathyroid hormone administration on condylar chondrocyte proliferation and differentiation.
        Biochem Biophys Res Commun. 2012; 424: 182-188
        • Yan J.Y.
        • Tian F.M.
        • Wang W.Y.
        • et al.
        Parathyroid hormone (1–34) prevents cartilage degradation and preserves subchondral bone micro-architecture in guinea pigs with spontaneous osteoarthritis.
        Osteoarthritis Cartilage. 2014; 22: 1869-1877
        • Yu Y.Y.
        • Lieu S.
        • Hu D.
        • et al.
        Site specific effects of zoledronic acid during tibial and mandibular fracture repair.
        PLoS One. 2012; 7e31771
        • Rowshan H.H.
        • Parham M.A.
        • Baur D.A.
        • et al.
        Effect of intermittent systemic administration of recombinant parathyroid hormone (1–34) on mandibular fracture healing in rats.
        J Oral Maxillofac Surg. 2010; 68: 260-267
        • Kudo S.
        • Mizuta H.
        • Takagi K.
        • et al.
        Cartilaginous repair of full-thickness articular cartilage defects is induced by the intermittent activation of PTH/PTHrP signaling.
        Osteoarthritis Cartilage. 2011; 19: 886-894
        • Perry A.C.
        • Prpa B.
        • Rouse M.S.
        • et al.
        Levofloxacin and trovafloxacin inhibition of experimental fracture-healing.
        Clin Orthop Relat Res. 2003; 414: 95-100
        • Chang J.K.
        • Chang L.H.
        • Hung S.H.
        • et al.
        Parathyroid hormone 1–34 inhibits terminal differentiation of human articular chondrocytes and osteoarthritis progression in rats.
        Arthritis Rheum. 2009; 60: 3049-3060
        • Novince C.M.
        • Entezami P.
        • Wilson C.G.
        • et al.
        Impact of proteoglycan-4 and parathyroid hormone on articular cartilage.
        J Orthop Res. 2013; 31: 183-190
        • Morita Y.
        • Ito H.
        • Ishikawa M.
        • et al.
        Subchondral bone fragility with meniscal tear accelerates and parathyroid hormone decelerates articular cartilage degeneration in rat osteoarthritis model.
        J Orthop Res. 2018; 36: 1959-1968
        • Chen Y.
        • Chen Y.
        • Zhang S.
        • et al.
        Parathyroid hormone-induced bone marrow mesenchymal stem cell chondrogenic differentiation and its repair of articular cartilage injury in rabbits.
        Med Sci Monit Basic Res. 2016; 22: 132-145
        • Orset E.
        • Chaffanjon P.
        • Bettega G.
        Temporomandibular joint model: anatomic and radiologic comparison between rat and human.
        Surg Radiol Anat. 2014; 36: 163-166
      1. Eli Lilly and Co: United States package insert: Forteo (teriparatide (rDNA origin) injection). Indianapolis, IN; 2002. Available from URL: (last accessed 5 April 2022).